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ABSTRACT
Purpose To evaluate if introduction of DNA nuclear Targeting
Sequences (DTS; i.e. recognition sequences for endogenous
DNA-binding proteins) in plasmid DNA (pDNA) leads to
increased transfection efficiency of non-viral gene delivery by
virtue of enhanced nuclear import of the pDNA.
Methods A set of DTS was identified and cloned into EGFP-
reporter plasmids controlled by the CMV-promoter. These
pDNA constructs were delivered into A431 and HeLa cells
using standard electroporation, pEI-based polyfection or lipo-
fection methods. The amount of pDNA delivered into the
nucleus was determined by qPCR; transfection efficiency was
determined by flow cytometry.
Results Neither of these DTS increased transgene expression.
We varied several parameters (mitotic activity, applied dose
and delivery strategy), but without effect. Although upregulated
transgene expression was observed after stimulation with TNF-
α, this effect could be ascribed to non-specific upregulation of
transcription rather than enhanced nuclear import. Nuclear
copy numbers of plasmids containing or lacking a DTS did not
differ significantly after lipofectamine-based transfection in
dividing and non-dividing cells.
Conclusion No beneficial effects of DTS on gene expression
or nuclear uptake were observed in this study.
KEY WORDS DNA.DNAnuclearTargetingSequences.
non-viralgenedelivery.nuclearimport
INTRODUCTION
Non-viral gene therapy is challenged by inefficient delivery
at the level of intracellular processing. Several barriers have
been described and studied, including failure to escape
from vesicular structures (1,2), lysosomal degradation,
enzymatic degradation in the cytosol (3), entrapment in
the highly viscous and crowded cytosol (4,5), lack of
transport towards the nucleus (6–9) and uptake into the
nucleus (10–15), and finally inefficiency of transcription
and/or translation (16–19). Capecchi et al. (20) showed that
microinjection of plasmid DNA directly into the nucleus
resulted in transgene expression in 50%–100% of the cells,
whereas cytoplasmic injection resulted in <0.01% of trans-
gene expressing cells. This observation clearly indicates that
transport into the nucleus is the major bottleneck for
successful non-viral gene delivery.
The nucleus is a double membrane organelle that is well-
separated from the rest of the cell. Exchange of molecules
requires transport via one of the approximately 2,000
nuclear pore complexes (NPCs) per nucleus (21). NPCs
allow passive diffusion of proteins up to 40 kDa or particles
of approximately 9 nm or DNA molecules of 210–350 bp
(4,22–24). These limits are well below sizes of DNA
complexes (~100–500 nm) and of plasmids (~6,000 bp)
generally used for gene delivery studies. Large macro-
molecules, such as viral proteins and host proteins with a
function in the nucleus (i.e. heterogeneous nuclear ribonu-
cleoprotein A1 (hnRNP), transcription factors, poly-
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DOI 10.1007/s11095-011-0407-8merases), are able to gain access to the nucleus. These
proteins were discovered to have consensus sequences,
called nuclear localization signals (NLSs), which can
interact with importin-α, importin-β or transportin. The
formed complexes are then docked to the NPCs, and the
protein is shuttled to the inner membrane of the nucleus.
Many efforts have been made to mimic this process by
incorporating NLSs in gene delivery complexes, mostly by
using the consensus sequence NLSs of the Simian Virus 40
(SV40) large T antigen, but unfortunately success has been
highly variable and generally disappointing (10,11,22,25–
33). An elegant alternative strategy was first presented by
Dean et al. Based on the finding by Graessmann et al. (34)
that an enhancer region within the SV40 viral DNA
facilitated nuclear import, Dean et al. examined usability
of this sequence for non-viral gene delivery and named it
DNA nuclear Targeting Sequence (DTS) (12,35–37). In
subsequent studies, it was found that the absence or
presence of the SV40 origin of replication and early
promoter region was critical for nuclear uptake of naked
plasmids from cytosol in the absence of cell division (35),
and a 72-bp region was identified to be sufficient to
establish this effect (36). Inhibitor studies revealed that
plasmid import occurred via the same pathway as signal-
mediated protein import and that transcriptional activity of
the cell was required for the process to occur (35). Based on
these findings, the following mechanism of DTS-mediated
nuclear uptake was postulated: (1) transcription factors
(TFs) present in the cytosol bind to their recognition
sequences present in the plasmid via their DNA-binding
domain, (2) NLSs naturally present in TFs interact with
importin-α and subsequently with importin-β, leading to
active transport towards the nucleus and docking of the
TF/plasmid complex to the NPC (12).
After establishing this principle, several applications and
variations have been studied. The DTS effect was shown to
occur in several cell types upon microinjection, electro-
poration and transfection (35–37) and was confirmed in vivo
(38–40). By replacing the heterogeneous SV40 sequence
that is responsive to various TFs, including NFκB and SP1,
by consensus sequences for nuclear factor kappa B (NFκB)
(41–43) or glucocorticoid responsive elements (GREs) (44),
plasmid import could be mediated via a specific pathway
and stimulated via TNF-α or corticosteroids, respectively.
In this study we aimed to further optimize the DTS
effect for non-viral gene delivery. A range of constructs with
various DTSs based on the heterogeneous SV40 DTS,
NFκB and GRE consensus sequences was prepared and
tested for their relative potential to enhance transfection
efficiency. Furthermore, the relation between cytosolic
accessibility of plasmid DNA, which is strongly carrier-
dependent, and the DTS effect was investigated by
comparing results upon electroporation (no carrier), trans-
fection with lipofectamine (dissociates prior to nuclear
uptake (45)) and transfection with 22 kDA linear pEI
(shown to deliver DNA into the nucleus as intact complexes
(41,46)). As we did not observe any significant differences
between the constructs tested, we continued to explore the
reason for this discrepancy with results published by others.
To be able to distinguish effects at the level of transcription
and of translocation, we quantified nuclear uptake of
plasmids by quantitative PCR on isolated cell nuclei.
MATERIALS AND METHODS
Materials
All chemicals and reagents were purchased from Sigma (St.
Louis, USA) unless stated otherwise. Other chemicals used
were Hepes (99%) and magnesium chloride, MgCl2·6H2O
(Acros Organics BVBA, Geel, Belgium); sodium chloride
and ethanol (Merck, Darmstadt, Germany); potassium
chloride (ICN Biomedicals, Aurora, USA); diethylether
(Biosolve, Valkenswaard, The Netherlands); phosphate-
buffered saline (PBS) (B. Braun MelsungenAG,Melsungen);
fetal bovine serum (FBS; Integro, Zaandam, The Nether-
lands), Trypsin/EDTA 10×, Plain DMEM (Dulbecco’s
modification of Eagle’s medium, with 3.7 g/l sodium bicar-
bonate, 1 g/l l-glucose, L-glutamine) and antibiotics/anti-
mycotics (penicillin, streptomycin sulphate, amphotericin B;
PAA Laboratories GmbH, Pasching, Austria), TNF-α (rh
TNF-α; R&D Systems, Minneapolis, USA).
TOPO TA Cloning Kit, TOP10 E. Coli bacteria,
propidium iodide (PI), Lipofectamine™2000 (lipofectamine),
Opti-MEM® I Reduced Serum Medium (optimem), Ultra-
Pure™ Buffer-Saturated Phenol (TE-saturated phenol) and
UltraPure™ Phenol:Chloroform:Isoamyl Alcohol (25:24:1,
v/v) were purchased from Invitrogen (Oregon, USA).
All restriction enzymes and other DNA-modifying
enzymes, RNase (RNase I, DNase- and protease-free),
Proteinase K (recombinant, PCR grade) and DNA
ladders were purchased from Fermentas (St. Leon-Rot,
Germany). The oligonucleotides used for PCR reactions,
sequencing and cloning were synthesized by Eurogentec
S.A. (Seraing, Belgium). NucleoSpin Extract II DNA
kits and Nucleobond PC Endotoxin Free kits for
plasmid purification were obtained from Bioke
(Macherey-Nagel, Bioke, Leiden, The Netherlands).
LabelIT Cy5 Nucleic Acid Labeling Kit was purchased
f r o mM i r u sB i o ,M a d i s o n ,W I ,U S A .
Cloning of Plasmid Constructs
Plasmid pCMV/EGFP was constructed from pShooter
(Invitrogen, Oregon, USA); the EGFP coding sequence from
1708 van Gaal et al.pEGFP-N1 (bp 613–1410; Clontech, Saint-Germain-en-
Laye, France) was amplified by PCR and cloned into the
multiple cloning site of pShooter from which the nuclear
localization signal (NLS)-tag coding sequence was removed
with NotI and XbaI restriction enzymes.
pCMV/EGFP was digested with DraIII and KasI to
remove the complete SV40 ori and enhancer region. After
purification from a 1% agarose gel, vector DNA was ligated
to a piece of synthetic DNA obtained by annealing
complementary oligonucleotides 1 (Table I), and ligation
product was transformed into E. coli TOP10 cells by
standard heat-shock procedure. Plasmids were isolated
using Nucleobond PC Endotoxin Free kits, and identities
were confirmed by restriction analysis and sequencing.
The resulting plasmid, pCMV/EGFP_noDTS_Sp1, was
further digested with BamHI and HindIII. The large
fragment was purified from a 1% agarose gel and either
blunted and self-ligated to result in plasmid pCMV/
EGFP_noDTS or ligated to pieces of synthetic DNA
obtained by annealing complementary oligonucleotides 2–
6 (Table I). Ligation products were transformed into E. Coli
Top10 bacteria, and plasmids were isolated using Nucleo-
bond PC Endotoxin Free kits. Plasmids were quantified by
260 nm absorbance measurement, and plasmid identity
and quality were analyzed on 1% agarose gels before and
after digestion and 260/280 ratio measurements. Sequen-
ces of all plasmid constructs were verified by sequencing
using oligo 7 (Table I) as primers (outsourced to Baseclear,
Leiden, The Netherlands).
DNA Labeling
Plasmids were covalently labeled with Cy5 according to a
modified version of the manufacturer’s protocol: DNA was
incubated overnight with a labeling mixture at room
temperature and purified using ethanol precipitation.
DNA was quantified and checked for purity by measuring
the absorbance at 260 and 280 nm in a Nanodrop
Spectrophotometer (Wilmington, DE USA). On average,
1 Cy5-molecule was bound per 150 bp, as calculated
according to the manufacturer’s instructions.
Cell Culture
Human epithelial ovarian carcinoma cells (HeLa) and human
epidermoid carcinoma cells (A431) were grown in DMEM
supplemented with antibiotics/antimycotics and 10% or
7.5% heat-inactivated FBS, respectively. Cells were main-
tained at 37°C in a 5% CO2 humidified air atmosphere and
split twice weekly. Both cell lines were kindly given by the
Institute of Biomembranes (Utrecht University, The Nether-
lands). Cells were confirmed to be free from mycoplasm by
periodical testing with a MycoAlert® Mycoplasma Detection
Kit (Lonza, Verviers, Belgium).
Table 1 Sequences of Oligonucleotides Used for Preparation of New Constructs (BamHI and HindIII)
1. Cloning
5′- GTGGGATCCCTAACTCCGCCCAGAAGCTTG-3′
3′-CATCACCCTAGGGATTGAGGCGGGTCTTCGAA -5′
2. 72-bp-repeat SV40 (based on (36))
5′- GGATCCGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAAAGCTTA-3′
3′-ACCTAGGCCACACCTTTCAGGGGTCCGAGGGGTCGTCCGTCTTCATACGTTTCGTACGTAGAGTTAATCAGTCGTTGGTTTCGAA -5′
3. 2xNFkB
5′- GGATCCTGGGGACTTTCCGCTGGGGACTTTCCGCAAGCTTA-3′
3′-ACCTAGGACCCCTGAAAGGCGACCCCTGAAAGGCGTTCGAA -5′
4. 3xNFkB
5′- GGATCCTGGGGACTTTCCGCTGGGGACTTTCCGCTGGGGACTTTCCGCAAGCTTA-3′
3′-ACCTAGGACCCCTGAAAGGCGACCCCTGAAAGGCGACCCCTGAAAGGCGTTCGAA -5′
5. 5xNFkB (based on (42,48))
5′- GGATCCTGGGGACTTTCCGCTGGGGACTTTCCGCTGGGGACTTTCCGCTGGGGACTTTCCGCTGGGGACTTTCCGCAAGCTTA-3′
3′-ACCTAGGACCCCTGAAAGGCGACCCCTGAAAGGCGACCCCTGAAAGGCGACCCCTGAAAGGCGACCCCTGAAAGGCGTTCGAA -5′
6. GRE (based on (44,48))
5′- GGATCCGGTACATTTTGTTCTAGAACAAAATGTACCGGTACATTTTGTTCTGGTACATTTTGTTCTAAGCTTA-3′
3′-ACCTAGGCCATGTAAAACAAGATCTTGTTTTACATGGCCATGTAAAACAAGACCATGTAAAACAAGATTCGAA -5′
7. Sequencing Kas to Dra
5′-GCCCGCTCCTTTCGCTTTCT-3′
3′-GACAACGTCGAGCACAGCT-5′
DNA Nuclear Targeting Sequences 1709Preparation of the Complexes
pEI-polyplexes were prepared at an N/P ratio of six by
adding four volumes of pEI (Exgen500; MBI Fermentas, St
Leon-Rot, Germany) solution to one volume of a 50 μg/ml
DNA solution, mixing by pipetting and incubating 30 min
at room temperature. pEI-polyplexes were prepared in
Hepes-buffered saline (20 mM Hepes, 150 mM NaCl;
pH 7.4 (HBS)). Lipofectamine-complexes were prepared at
a ratio of 2 μl lipofectamine per 1 μg DNA by adding four
volumes of lipofectamine solution to one volume of a
50 μg/ml DNA-solution (both diluted in optimem), mixing
by pipetting and incubating 30 min at room temperature.
Transfection
For studies in dividing cells, 40,000 (HeLa) cells were seeded
per well into 24-well tissue culture plates 24 h prior to
transfection, such that 60%–70% confluency was reached on
thedayoftransfection.Forstudiesin non-dividingcells,40,000
(HeLa) cells were seeded per well into 24-well tissue culture
plates 48 h prior to transfection, and medium was replaced by
complete medium supplemented with 15 μM aphidicolin.
Cells were continuously exposed to aphidicolinfrom at least 16
hours prior to transfection until time of analysis.
Immediately prior to transfection, the culture medi-
um was refreshed with 500 μlD M E Mm e d i u m ,
supplemented with 10% FBS (and 15 μM aphidicolin
where applicable). One hundred μl of the polyplex or
lipoplex samples (corresponding to 1 μg DNA/well)
were added per well, and after 4 h incubation, medium
was replaced with fresh DMEM supplemented with
10% FBS (and 15 μM aphidicolin where applicable).
Cells were incubated for indicated times at 37°C in a
5% CO2 humidified air atmosphere until analysis.
Experiments were performed in triplicate.
Electroporation
Cells were harvested by trypsin/EDTA (T/E) treatment,
counted and diluted to 1.1·10
6 cells/ml in 20 mM Hepes in
PBS (pH 7.4). DNA was diluted to 2 μg DNA (or as
indicated) into 25 μl Hepes buffer. Twenty five μlD N A
solution was added to 225 μl cell suspension and incubated
on ice for 10 min. After addition of 250 μl Hepes buffer,
the sample was transferred into an electroporation cuvette
and electroporation was performed 250 mV for 7 msec
(Electro Square Porator ECM830 with Safety Stand 630B
and Electroporation Cuvettes Plus no 640 4 mm GAP
cuvettes; BTX, San Diego, USA). Cells were left to
equilibrate for at least 10 min, transferred into an
Eppendorf tube and mixed with 500 μl completed medium.
From this, a suitable volume was transferred into a 24-well
plate and incubated for indicated times at 37°C in a 5%
CO2 humidified air atmosphere until analysis.
Cell Cycle Analysis
ToconfirmarrestofcellsintheS-phase,cellcycleanalysiswas
performed based on flow cytometric analysis of cell DNA
content following cell staining with propidium iodide (Fig. 1).
After synchronization treatment, the cells were washed two
times with PBS to ensure removal of all dead cells, harvested
and fixed. Fixation was achieved by incubating the cells in a
300 μlP B S / 7 0 0μl ethanol solution at −20°C for at least
1 h. After fixation the ethanol/cell solution was underlayered
with 1 ml FCS before being spinned down and resuspended
in 500 μl( f o r1 · 1 0
6cells) PBS containing PI and RNase
(930 μlP B S ,5 0μl PI (1 mg/ml), and 20 μl RNAse (5 mg/
ml)). After 1 hour incubation at room temperature the cells
were analyzed with a FACSCantoII cytometer (Becton and
Dickinson, Mountain View, CA, USA) equipped with a
488 nm 20 mW Solid State diode laser and a 633 nm
20 mW HeNe laser. Ten thousand cells were recorded per
sample, and cell cycle analysis of DNA profiles was
performed using Cylchred software, available from Cytonet
UK.
Stimulation of NFκB
Cells were incubated for 3 h with poly- or lipoplexes, after
which the medium was replaced by 500 μl complete
untreated aphidicolin
G1
G2/M
S
Fig. 1 Arrest of HeLa cells
in S-phase by treatment with
15 μM aphidicolin.
1710 van Gaal et al.medium supplemented with 25 ng/ml TNF-α.A f t e r
another 3 h incubation, cells were harvested and analyzed.
Flow Cytometry
Forty eight hours after transfection, cells were washed,
trypsinized and resuspended in DMEM supplemented with
10% FBS to inactivate the trypsin. Cells were transferred
into round-bottom 96-well plates and centrifuged for 5 min
at 250×g at 4°C. Medium was removed and cells were
resuspended in 200 μl phosphate-buffered albumin (PBA;
1%, w/v albumin in PBS). Immediately prior to measure-
ment, 20 μl of a PI solution (10 μg/ml in water) was added
for live/dead cell discrimination. Flow cytometric analysis
was performed on a FACSCantoII (Becton and Dickinson,
Mountain View, CA, USA) equipped with a 488 nm
20 mW Solid State diode laser and a 633 nm 20 mW HeNe
laser. A live gate was set on the viable cell population in
FSC-SSC plot, and from this, the percentage of positive
cells was obtained by setting a gate in the FL1-FL3 plot to
exclude all PI-positive and FL1-negative cells. Ten thou-
sand cells were recorded per sample, to determine EGFP
expression (FITC-channel) and PI-staining (PE-channel).
Quantification of Nuclear Localization by Cell
Fractionation and Q-PCR
Quantification of plasmid copies delivered to nuclei was
performed based on a method developed by Cohen et al.
(47). Transfection procedures were similar as described
above, but were upscaled to T75 culture flasks per sample:
1.8·10
6 cells were seeded per flask, and transfections were
performed at a dose of 18 μg per flask.
Isolation of Cell Nuclei
Twenty four hours after transfection, cells were har-
vested, and nuclei were isolated by swelling in 1 ml
hypotonic buffer (10 mM PIPES pH 7.4, 1 mM DTT,
2 mM MgCl2, 10 mM KCl) for 25 min followed by
lysis in a Dounce homogenizer (Wheaton, VWR
International BV, Amsterdam, The Netherlands) with
50 strokes of the tight pestle. Cell lysates were mixed
with equal volumes of 50% iodixanol (Optiprep Density
Gradient Medium; Sigma-Aldrich, St. Louis, USA) in
isotonic buffer (10 mM Na2HPO4,1m MM g C l 2,
130 mM KCl, pH 7.4). Single particle optical sensing
(SPOS) was used to confirm that cells were lysed and
nuclei were intact.
A three-step discontinuous iodixanol gradient was
prepared by first underlaying 3 ml of 30% and 35%
iodixanol in isotonic buffer and then carefully adding the
cell lysate (in 25% iodixanol) on top. After spinning for
40 min at 10,000×g at 4°C in a swing-out rotor (Beckman
OptimaTM LE-80 K Ultracentrifuge with SW41-TI rotor,
Beckman Coulter B.V., Woerden, The Netherlands), nuclei
were recovered from the 30/35% interface with a 18-gauge
needle (Sterican 18 G×1 ½″; B. Braun Melsungen AG,
Melsungen, Germany).
Total DNA Extraction
Isolated nuclei were lysed by treatment with 0.5% SDS,
100μg/mlproteinaseKand20μg/mlRNasefor5hat50°C.
Total DNA was recovered by subsequent extractions with
equal volumes of TE-saturated phenol (1×) and phenol:
chloroform:isoamyl alcohol 25:24:1 (2×) followed by washes
with water-saturated ether (2×). DNA was precipitated from
the final water phase with 1/10 V sodium acetate (3 M,
pH 5.2) and 2 V ice-cold 96% ethanol incubated overnight at
−20°C. After washing the DNA pellet with 70% ethanol, the
pellet was air-dried and dissolved in MilliQ-water. Samples
were used directly or stored at −20°C.
Quantification of Plasmid and Genomic Actin DNA Copies
by Q-PCR
Actin copies were quantified using Taqman Gene Expres-
sion Assay Hs03023880_g1 (Applied Biosystems, Foster
City, USA), which contains primers, and a FAM-labeled
TaqMan MGB probe to amplify human genomic β-actin
DNA. PCR reaction mixtures were prepared containing
5 μl DNA (2–2,000 fg), 1 μl Taqman gene Expression
Assay, 10 μl 2× TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, USA) and MilliQ-water
added to a final volume of 20 μl. PCR was performed using
a two-temperature thermal cycling program consisting of
15 s at 95°C and 60 s at 60°C for 40 cycles. A standard
curve of plasmid pAct, which contains the human β-actin
sequence (pCMV-Sport6 containing the complete CDS for
Homo sapiens actin, beta, mRNA (cDNA clone
MGC:5475 IMAGE:3451917); Invitrogen, Oregon, USA)
was used to calibrate the PCR system.
Plasmid DNA was quantified with a SYBR Green assay
using a three-temperature thermal cycling program con-
sisting of 10 s at 95°C, 10 s at 61°C and 30 s at 72°C for 40
cycles. Primers were designed to specifically amplify a
116 bp region from the ampicillin CDS using VectorNTI
(Invitrogen) and Primer-BLAST (available from NCBI)
software and are of the following sequence: forward 5′-
TCC-ATA-GTT-GCC-TGA-CTC-CC-3′ and reverse 5′-
GAT-AAA-TCT-GGA-GCC-CGT-GA-3′. PCR reaction
mixtures consisted of 5 μl DNA (2–2,000 fg), 250 nM
forward primer, 250 nM reverse primer, 10 μl iQ SYBR
Green Supermix (Bio-Rad, Hercules, USA) and MilliQ-
water added to a final volume of 20 μl. A standard curve of
DNA Nuclear Targeting Sequences 1711known amounts of plasmid pAct was used to calibrate the
PCR system.
Since 2 actin copies are present per genome per cell, the
number of plasmids per nucleus was calculated as # plasmid
copies/(# actin copies/2).
Experimental Setup and Statistical Analyses
On each experimental day, three independent plasmid/
carrier preparations were made and tested on the same
batch of cells.
RESULTS
Design and Cloning of Plasmid Constructs
To study and compare effects of various DTSs on gene
delivery efficiency, DTSs were identified from literature
(35,36,42,44,48), and a range of plasmid constructs were
prepared as described in the Materials and Methods
section. The SV40 origin/promoter sequence was excised
from pCMV/EGFP to obtain the control plasmid pCMV/
EGFP_noDTS. Subsequently, the SV40 72-bp repeat, a
repetition of 2, 3 or 5 NFκB consensus binding sites, or a
glucocorticoid responsive element was inserted at the
position where the SV40 ori/promoter sequence previously
was located (Fig. 2). Successful modifications were con-
firmed by sequencing.
Effect of DNA Nuclear Targeting Sequences
on Transfection Efficiency
HeLa cells were transfected with plasmids containing the
completeSV40 promoter/origin region,plasmidsfromwhich
this complete region was deleted and plasmids in which a
DTS region was inserted: 72-bp enhancer region of SV40, 2-
3-5× NFκB binding sites or a glucocorticoid responsive
element (GRE). Gene expression was analyzed 6 h after the
start of transfection to minimize effects of mitosis. As shown in
Fig. 3, no significant differences between the plasmid lacking
a DTS sequence and any of the constructs containing a DTS
were observed. This means that presence or absence of a
DTS did not affect the number of cells that is successfully
transfected. Since it is possible that the DTS did have an
effect on the amount of transgenes expressed per successfully
transfected cell, we also looked at the mean fluorescence
intensity (MFI), but no differences were observed (data not
shown). Next, we tested if TNF-α stimulation could induce
uptake of the NFκB-based constructs. Treatment with TNF-
α induces activation of NFκB leading to nuclear transloca-
tion of NFκB. It is therefore expected that plasmids
containing NFκB binding sites are preferentially shuttled
into the nucleus. Figure 3b shows that transfection efficiency
for the NFκB-plasmids was indeed enhanced (again, similar
trends were observed when analyzing MFI). However,
transfection efficiencies were increased to a similar extent
for all other constructs tested. Stimulation of gene expression
was similar for plasmids containing the full SV40 promoter/
pCMV/EGFP_noDTS
4892 bp
egfp
pCMV/EGFP
5569 bp
Neo(R)
Amp(R) Amp(R)
EGFP
SV40 72bp-repeat
SV40 72bp-repeat
SV40 pA
SV40 pA
BGH pA
BGH pA
CMV promoter CMV promoter
SV40 promoter/origin
f1 origin
pUC origin
pUC origin
DraIII (1936) DraIII (1936)
KasI (2627)
KasI (1950) SV40 
SV40 7
SV
Inserts:
72bp region SV40
GGATCCGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAAAGCTT
2 5xNF
GGATCC(TGGGGACTTTCCGC) 2-3-5AAGCTT
GRE
GGATCCGGTACATTTTGTTCTAGAACAAAATGTACCGGTACATTTTGTTCTGGTACATTTTGTTCTAAGCTT
B 3
Fig. 2 Design and cloning of plasmid constructs.
1712 van Gaal et al.ori region, the minimized 72-bp SV40 region or plasmids
from which the entire SV40 regulatory region was removed
(Fig. 3a). Lastly, a plasmid from which the SV40 region was
replaced by a glucocorticoid responsive element (GRE)
responded similarly to TNF-α treatment as the plasmids
containing several NFκB binding sites (Fig. 3c).
These results show that the stimulation induced by TNF-α
was unspecific and is most likely related to upregulation of
transcriptional processes. The plasmids tested were all under
transcriptional control of the CMV-promoter, and this
promoter contains three NFκB binding sites, which may
explain the transcriptional activation upon TNF-α stimula-
tion. Interestingly, despite the presence of these NFκBs i t e s ,
the CMV-promoter itself was previously described not to be
involved in nuclear import processes (36,41).
Since we did not manage to achieve DTS-mediated
increase in transfection efficiency with any of the constructs
tested, we continued to examine the parameters that could
be critical in obtaining sequence-specific nuclear uptake.
For this, we selected the pCMV/EGFP (DTS) and pCMV/
EGFP_noDTS (noDTS) for proof-of-principle studies.
Effect of Delivery Strategy on DTS Effect
The suggested mechanism of DTS-induced nuclear uptake is
sequence-specific binding of NLS-containing transcription
factors to plasmid DNA that is delivered into the cytosol,
followed by import of the formed TF/plasmid complexes into
the nucleus. This implies that the plasmid is delivered into the
cytosolandthattheDNAisavailableforinteractionwiththose
proteins. It is therefore expected that escape from vesicles and
(partial) dissociation from the carrier is essential for the DTS
effect to occur. To test if the type of delivery affected
occurrence of the DTS effect, three methods to introduce
plasmid into cells were tested. Lipofectamine was used as a
transfection reagent which has been described to release DNA
prior to nuclear uptake and transcription (45). In contrast,
22 kDa linear pEI is thought to deliver DNA into nuclei as
intact complexes (41,46,49) and has even been described to
allow transcription to occur while still bound to the plasmid
(16). Electroporation was used to introduce naked DNA
directly into the cytosol, bypassing vesicular uptake and
release and unpackaging of complexes. Figure 4 shows that
regardless of the delivery strategy chosen, no differences in
transgene expression efficiency were observed for plasmids
containing or lacking a DTS. Neither the % of transfected
cells nor the mean EGFP expression per cell differed
significantly for plasmids containing or lacking the DTS.
Dependency of the DTS Effect on Mitosis
In the previous experiments, transfections were performed
in dividing cells. Possibly, benefits in increased active
a
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Fig. 3 The effect of various DTS on transfection efficiency. % EGFP-
expressing cells after transfection with SV40-based DTS (a), NFκBD T S( b)
and a GRE DTS (c). HeLa cells were transfected with the indicated plasmids
and lipofectamine for 4 h in the presence of serum, washed and analyzed
6 h after the onset of transfection. Cells were non-stimulated (light grey bars)
or stimulated by incubation with 25 ng/ml TNF-α during time of transfection
(dark grey bars). Data are presented as mean ± SD (n=3). One-way
ANOVA followed by post hoc analysis with Bonferroni correction was
performed on the expression data of each plasmid. None of the plasmids
differed significantly from plasmid noDTS either in the presence or absence
of TNF-α.
DNA Nuclear Targeting Sequences 1713uptake are outweighed by bulk access to the nucleus when
the nuclear envelope is temporarily broken down at the
time of mitosis. The shortest incubation time tested was 6 h,
which is well below the cycling time of HeLa cells.
Nevertheless, due to the asynchronous nature of cultured
cells, a fraction of cells will still be undergoing mitosis
within this interval. To minimize this fraction even further,
cells were incubated with aphidicolin, a reagent that arrests
cells in S-phase by interfering at the level of DNA synthesis
and with relatively mild cytotoxicity (50). Results obtained
in HeLa cells after lipofectamine-based transfections of
plasmids containing or lacking the SV40 DTS are shown in
Fig. 5 (left panel). Again, no significant difference between
the two plasmid constructs was observed, regardless of
incubation time, and, most importantly, no effect was
observed in non-dividing cells. Similar results were
obtained in a second human cell line, A431 (Fig. 5, right
panel).
DTS Effect and Amount of Plasmids Delivered
into the Cytosol
Dean et al. hypothesized that a DTS effect may be
overshadowed when using large amounts of plasmids as
this may lead to some plasmids being taken up into the
nucleus irrespective of any DTS effect (12). In support of
this hypothesis, Utvik et al. (51) have reported a threshold
level of 10
6 plasmid copies/cell above which nuclear uptake
occurs in the absence of cell division and in the absence of
any active nuclear targeting strategy.
In our transfection experiments a dose of 1 μg DNA per
well of a 24-well plate is applied, which corresponds to
roughly 2·10
6 plasmids/cell. It is not expected that 100% of
the applied dose is taken up by cells; therefore, it is
unlikely that under the conditions used the threshold
reported by Utvik et al. (51) is exceeded. Nevertheless, it is
unknown if the reported threshold applies to different cell
types. Therefore, to fully exclude the phenomenon of mass
action, an experiment was performed in which the numbers
of plasmids dosed per cell were decreased and both the
actual amount delivered into the cells and the transgene
expression were monitored. In the first experiment, HeLa
cells were electroporated with various amounts of plasmids
with or without DTS, and gene expression was measured
24 h after electroporation (Fig. 6a). Transfection efficiency
was similar for the two plasmid constructs at all amounts
tested. Up to a dose of 1 μg, each two-fold increase in
applied dose resulted in a two-fold increase in the %
successfully transfected cells. At doses exceeding 1 μg, a
saturation effect was observed, and a maximum number of
transgene-expressing cells of approximately 50% was
reached. When looking at the mean expression per cell,
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Fig. 4 Dependency of the DTS effect on delivery strategies. % of EGFP-expressing cells (a) and mean expression per cell (b) after transfection with
lipofectamine (left), 22 kDa linear pEI (middle) or after electroporation (right) of plasmids with DTS (pCMV/EGFP; dark grey bar) versus plasmids without
DTS (pCMV/EGFP_noDTS; light grey bar). Cells were transfected at a dose of 1 μg DNA/well in a 24-well plate with lipofectamine or pEI for 4 h in the
presence of serum, washed and analyzed after 48 h or electroporated at a dose of 2 μg/2.25·10
5 cells and analyzed after 24 h. Data are represented as
mean ± SD of three independent measurements. MFI: mean fluorescence intensity.
1714 van Gaal et al.again a dose-response relation is observed. However, the
expression per cell increases only by a factor two upon a
sixteen-fold increase in dose. This shows that once a cell is
successfully transfected, the number of plasmids transfected
is not an important parameter for overall transfection
efficiency. Possibly, transcription and/or translation pro-
cesses become rate-limiting at this stage. A second exper-
iment was performed in which cells were treated similarly,
but gene expression was measured 4 h after electroporation
to minimize effects of cell division (Fig. 6b). Since the
proportion of cells passing through mitosis in the course of
the experiment is largely reduced, DTS-mediated nuclear
import was expected to become more apparent. The results
show that very few cells (<3%) were transfected, indepen-
dent of the presence of the DTS. This indicates that the
DTS was inefficient in mediating active nuclear uptake and
subsequent transgene expression in the large fraction of
non-dividing cells within the total cell population. Similar
to the trends observed after 24 h incubation, DNA dose
predominantly affected the % of transfected cells and, to a
much lesser extent, the expression per cell.
In these experiments, the highest plasmid dose used was
2 μg DNA/2.25·10
5 cells, which corresponds to delivery of
maximally 1.5·10
6 plasmids/cell. This dose is close to the
critical dose of 1·10
6 described by Utvik et al., but is most
likely a gross overestimation of the actual amount of
plasmids delivered. To check this, how much of the applied
dose was actually delivered into the cells after electro-
poration was quantified by measuring plasmid copy
numbers relative to actin copy numbers by Q-PCR on cell
lysates. After electroporation of 1.8 μg/2.25·10
5 cells
(corresponding to 1.3·10
6 plasmids/cell), an average plas-
mid copy numbers/cell of 1.5 (±0.6)·10
3 was detected. This
confirms that the number of plasmids that reached the cell
cytosol in these experiments was well below the levels
described by Utvik et al., making it unlikely that the DTS
effect was masked by unspecific nuclear uptake due to
overloading of the cytosol.
DTS Effect Observations at Level of Localization
or Expression
The efficiency of nuclear delivery for plasmids containing
or lacking a DTS was evaluated by isolating nuclei from
transfected cells and quantification of plasmid copies by Q-
PCR. The number of genomic actin copies was determined
for use as an internal standard representing the number of
cells (cell nuclei). Hypotonic swelling followed by Dounce
homogenization rather than detergent-based cell lysis was
used for cell fractionation, as this was previously described
to yield a pure nuclear fraction with minimal contamina-
tion of cytoplasmic components (47). First, Q-PCR was
performed on total cell lysates to determine the efficiency of
uptake into cells. After incubation of cells with complexes
for 4 h, and an additional hour in the absence of
complexes, cells were harvested and analyzed. As shown
in Table II, transfection of pCMV/EGFP with lipofect-
amine resulted in 5.4 (±1.8)·10
2 copies per cell in dividing
cells (versus 3.4 (±1.7)·10
2 for pCMV/EGFP_noDTS;
difference is not significant). This number remained
constant up to 24 h after transfection, indicating that little
intracellular elimination occurred. Similarly, Ruponen et al.
(52) found little elimination of plasmid DNA within 24 h
after transfection with cationic liposomes.
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Fig. 5 Dependency of the DTS effect on mitosis. % of EGFP-expressing cells (bars; left y-axis) and MFI of positive cells (lines; right y-axis) after transfection
of HeLa cells (left panel) or A431 cells (right panel) with plasmids with DTS (pCMV/EGFP; dark grey bar and asterix) versus plasmids without DTS (pCMV/
EGFP_noDTS; light grey bar and open circle). Cells were transfected at a dose of 1 μg DNA/well in a 24-well plate with lipofectamine for 4 h in the
presence of serum, washed and analyzed at the indicated timepoints after onset of transfection. As a model for non-dividing cells, cells were arrested at the
S-phase by treatment with 15 μM aphidicolin starting 24 h prior to transfection and continuously throughout the experiment. Data are represented as
mean ± SD of three independent measurements.
DNA Nuclear Targeting Sequences 1715Next, nuclei were isolated from transfected cells, and
plasmid copy numbers/nucleus were determined (Table II).
The number of plasmids per nucleus 24 h after transfection
was 1.8 (± 0.8)·10
2 (versus 2.4 (±1.6)·10
2 for pCMV/
EGFP_noDTS; difference is not significant), corresponding
to ~40% of total cellular plasmid DNA. During the 24 h
incubation, cells will have undergone at least one mitotic
event during which plasmids gain bulk access into the nuclei,
which may explain the high % found in nuclei. The situation
in non-dividing cells was rather different. Twenty four hours
after transfection of aphidicolin-arrested cells, 1.7 (±0.6)·10
3
plasmid copies were detected per cell (compared to 5.4(±
1.8)·10
3 for pCMV/EGFP_noDTS; difference is not signif-
icant). Treatment of cells with aphidicolin has previously
been described not to affect the rate of uptake of lipid/DNA
complexes (53). The increased number of copies detected per
cell as compared to dividing cells probably simply reflects the
lower number of cells present in the absence of division.
More importantly, the number of plasmid copies detected
per nucleus was decreased to 2%–4% of total cellular
plasmid DNA. This confirms that in the absence of mitosis,
transport of DNA into the nucleus is severely diminished
(although not completely abolished). The difference between
copy numbers detected per nucleus after transfection with
plasmids with or without DTS was not significant (7.5
(±2.7)·10
1 versus 3.4 (± 1.1)·10
1).
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Fig. 6 Dose-dependent gene expression upon electroporation. HeLa cells were electroporated with varying doses of plasmids containing or lacking a
DTS and analyzed for EGFP expression by flow cytometry either 24 h (a)o r4h( b) after electroporation. Gene expression drops with decreasing plasmid
amounts regardless of the presence or absence of a DTS.
1716 van Gaal et al.When comparing pEI and lipofectamine, large differ-
ences in detected copy numbers were observed. At times of
5–24 h after the start of transfection, roughly 2·10
4
plasmids were detected per cell in dividing cells when pEI
was used as delivery agent. This is two orders of magnitude
more than observed for lipofectamine. Again, copy numb-
ers per cell were increased in aphidicolin-arrested cells.
While collecting nuclei of pEI-transfected cells after
ultracentrifugation through a discontinuous iodixanol gra-
dient, we noticed the presence of aggregates at the 30/35%
interface which we did not observe during processing of
lipofectamine-transfected cells. This is probably due to
adherence of extranuclear plasmid DNA (−complexes) to
the nuclei followed by aggregation and indicates that in our
hands the method failed to yield pure nuclei devoid of
extranuclear plasmid (−complexes) in case of pEI-
transfected cells. Analysis of the nuclear fractions showed
that nuclear copy numbers did not differ from- or even
outnumbered- total cellular copy numbers, which further
supports our assumption that we failed to isolate clean
nuclei. At the time of this writing efforts to further optimize
and validate the method were still ongoing. Results
obtained for pEI-based delivery therefore remain elusive.
Nevertheless, in the experiments performed with lipofect-
amine no significant enhancement of plasmid nuclear
localization that could be ascribed to the DTS effect could
be detected.
DISCUSSION
In this paper, the relevance of DNA nuclear Targeting
Sequences for improving efficiency of non-viral gene
delivery was evaluated. Several DTSs were identified from
literature and cloned downstream of an EGFP coding
sequence that was under the control of the CMV-promoter.
It was shown that insertion of either the full-length SV40
DTS (372 bp promoter/origin region), the partial SV40
DTS (72-bp enhancer region), repetitive NFκB binding
sites or a glucocorticoid responsive element did not increase
transgene expression. Additionally, preliminary findings
showed that cloning of multiple repeats of the SV40 DTS
had no beneficial effect on transfection efficiency (data not
shown). It was shown that expression levels could be
augmented by activation of the NFκB pathway through
TNF-α stimulation. However, this effect was not restricted
to plasmids containing NFκB inserts, but also observed to a
similar extent for all the other plasmids tested. This
indicates that the effect is more likely related to unspecific
transcriptional upregulation rather than NFκB specific
nuclear import. In the plasmids used in this study,
transcription is driven by the CMV promoter, which
contains three NFκB binding sites and could therefore be
upregulated by TNF-α-induced NFκB activation. Interest-
ingly, these sites seem to have no role in nuclear targeting,
as Dean et al. (36) showed unability of the CMV promoter
to direct nuclear localization of plasmid after cytoplasmic
microinjection. The presence of NFκB sites and their
apparent unability to function as DTS remains unaddressed
in his paper. In two papers by Gonçalves et al. and
Breuzard et al., the importance of spacing between
transcription factor binding sites is addressed, and it is
suggested that the separation between the individual NFκB
sites (142 and 152 bp) within the CMV-promoter are not
optimal to mediate NFκB-mediated nuclear import, but
would be able to induce transcriptional enhancement
(41,54).
It was shown that the presence of the full-length SV40
DTS did not enhance transfection efficiency regardless of
mitotic activity of cells. We aimed to compare three
Table II Cellular and Nuclear Delivery of Plasmids with and without DTS in Dividing and Aphidicolin-Arrested Cells. The Number of Plasmid Copies per
Cell or per Nucleus was Determined after Transfection with 22 kDa Linear pEI or Lipofectamine. Cells were Transfected at a Dose of 18 μg DNA/T75-
flask (or 2.3 μg/well in 6-well Format) with Lipofectamine or pEI for 4 h in the Presence of Serum, Washed and Analyzed after 24 h (or 5 h). As a Model
for Non-dividing Cells, Cells were Arrested at the S-phase by Treatment with 15 μM Aphidicolin Starting 24 h Prior to Transfection and Continuously
throughout the Experiment. Data are Represented as Mean±SD of Three Independent Measurements
l-pEI Lipofectamine
+DTS -DTS +DTS -DTS
Dividing cells
4+1 h # plasmids/cell 2.7±0.8×10
4 2.7±1.3×10
4 5.4±1.8×10
2 3.4±1.7×10
2
24 h # plasmids/cell (C) 1.4±0.2×10
4 1.9±0.5×10
4 4.9±2.8×10
2 2.8±0.9×10
2
24 h # plasmids/nucleus (N) 2.1±0.3×10
4 8.0±6.2×10
4 1.8±0.8×10
2 2.4±1.6×10
2
Aphidicolin-arrested cells
24 h # plasmids/cell (C) 9.8±3.9×10
4 2.3±1.3×10
5 1.7±0.6×10
3 5.4±1.8×10
2
24 h # plasmids/nucleus (N) 7.4±5.3×10
4 1.3±0.2×10
5 7.5±2.7×10
1 3.4±1.1×10
1
DNA Nuclear Targeting Sequences 1717delivery methods to gain insight into whether the DTS is
available for interaction with transcription factors after
delivery into the cell. Contrary to the situation after
electroporation, after transfection with lipids or polymers
the DNA is present in a condensed form, and we
hypothesized that this might interfere with binding of
transcription factors. However, no DTS effect was observed
for any of the delivery methods chosen (condensed/not-
condensed). Dose-response experiments excluded the possi-
bility that relatively small increments in specific nuclear
uptake were outweighed by overloading the cytoplasm with
plasmid DNA, which could potentially lead to unspecific
nuclear uptake. Finally, it was evaluated whether effects of
DTS could be detected at the level of translocation rather
than expression. Results from quantitative PCR on nuclear
fractions indicate that nuclear localization of plasmids was
not facilitated by the presence of the full-length SV40 DTS.
Overall, the beneficial effects of DTS on transfection
efficiency were much less than we expected based on
findings from literature. Prasad et al. (55) also question the
effect of an SV40 DTS on transfection efficiency of CMV-
plasmids. In their study, constructs with no SV40 DTS, the
complete SV40 DTS or the 72-bp repeat were used to
perform transient gene expression assays in various cell
types. It was observed that gene expression from DTS-
containing plasmids compared to expression from plasmids
lacking a DTS varied with cell type and plasmid backbone
used. In support of our data, they did not observe any
beneficial effects in HeLa-cells. The authors conclude that
effects of the SV40 DTS on overall gene expression are
only weakly dependent on facilitated nuclear import. Other
factors governing overall transfection efficiency would be
enhancement of transcription and replication of plasmids
containing the SV40 origin of replication in SV40-
transformed cells such as COS-7. Unfortunately, no data
regarding nuclear localization efficiency are included;
therefore, these statements remain speculative.
In our study, we attempted to study the effect of DTS at
the level of nuclear localization efficiency by performing
quantitative PCR on isolated nuclei. Studies presenting
data on quantification of intranuclear plasmids are still
limited, although important progress has been made in the
past years. Various methods have been described, including
microscopic analysis based on FISH detection (35,56),
sometimes combined with FRET or FRAP effects (41).
Drawbacks of these techniques are the need for fluorescent
labeling and consequent artifacts (especially if DNA is
labeled prior to transfection (57)), detection limits, resolving
power to discriminate internal from adhered DNA and
poor statistical power related to the low number of cells
analyzed. Alternatively, methods based on cell fractionation
and quantification of DNA in the nuclear fraction have
been described. Isolated nuclei were previously analyzed by
flow cytometry (14,58,59), Southern blotting (60)o r
quantitative PCR (17,47,60,61). Analysis by flow cytometry
seems the fastest and simplest option, but requires fluores-
cent labeling of DNA and is complicated by low yields of
isolated nuclei (personal communication) and leakage of
compounds out of the nuclei (14). Q-PCR offers a sensitive
and quantitative analysis on non-modified plasmid DNA
and was chosen here. A general concern in cell fraction-
ation is cross-contamination among fractions, in our case
contamination of the nuclear fractions with extranuclear
DNA (complexes). The majority of cell fractionations is
performed after cell lysis with detergents (14,17,58–61).
Cohen et al. (47) showed that detergent-lysis induces
aggregation of nuclei and adsorption of DNA (complexes)
to the outer membrane of the cell nuclei. Moreover, they
show that this plaque could not be sufficiently removed by
treatment with competitive agents (pASPA, DNA) or
restriction enzymes. They developed an alternative method
where cells are lysed by hypotonic swelling followed by
Dounce homogenization, which is described to yield clean
nuclei largely free from plaque.
Using this method, we found nuclear plasmid copy
numbers of 1.8 (±0.8)·10
2 and 2.4 (±1.6)·10
2 after
lipofectamine-based transfection of dividing cells with
pCMV/EGFP and pCMV/EGFP_noDTS, respectively.
We used a dose of 18 μg DNA/T75 flask seeded with
1.8·10
6 cells, and taking into account the doubling time of
cells, this corresponds to a dose of roughly 8·10
5 plasmid
copies/cell. In comparison, Cohen et al. (47) detected
approximately 1·10
3 plasmid copies per nucleus after
transfection with either linear pEI or lipofectamine at a
dose of 1·10
5 plasmid copies per cell. Tachibana et al. (60)
report nuclear delivery of 1·10
4 plasmid copies per nucleus
after transfection with cationic liposomes and a dose of
20 μg/5
.10
6 cells, which is slightly less than doses used by
us. Hama et al. (61) recovered 1.7·10
4 plasmid copies per
nucleus from cells transfected with lipofectamine at a dose
of 2.5 μg/2.5·10
5 cells. The latter two studies used
detergent-lysis, which could explain the higher copy
numbers found. James and Giorgio (58) used flow cyto-
metric analysis of fluorescence in isolated nuclei and found
1,250 pCMV-plasmids per nucleus in Hela cells 4 h post-
transfection with cationic liposomes (dose 1.25 μg/2
.10
5
cells). Breuzard et al. (41), who used microscopic analysis for
quantification of nuclear delivery, report lower numbers:
approximately 368 copies/nucleus in cells transfected with
pCMV/luc complexed with linear pEI (dose 0.5 μg/1·10
4
cells). These data show that copy numbers found by us after
transfection in dividing cells are within the expected range
(at the lower end). In non-dividing cells, we detected 7.5
(±2.7)·10
1 versus 3.4 (±1.1)·10
1 plasmid copies/nucleus for
pCMV/EGFP and pCMV/EGFP_noDTS, respectively.
To our knowledge, no previous attempts have been
1718 van Gaal et al.described to quantify nuclear uptake in aphidicolin-arrested
cells. The difference in plasmid copy numbers/nucleus
resulting from transfection of either dividing or non-
dividing cells with plasmid containing or lacking the SV40
DTS was not significant. Previous studies investigating the
role of DTS in gene delivery relied on microscopic
techniques to evaluate nuclear uptake. Discrepancies
between findings regarding the effect of DTS on nuclear
localization might be inherent to differences in methods
chosen. At this stage, the presence of extranuclear plaque
cannot be fully excluded, and this could obscure subtle
differences in intranuclear copy numbers. Additionally, it
should be mentioned that the method used in this study is
based on batch analysis of DNA in pooled nuclear fractions,
leaving heterogeneity among cells within a population
unconsidered. Using microscopic techniques offers the
ability to study individual cells and take into account
heterogeneity by quantifying both the number of plasmid-
positive nuclei and ranking the signal within these nuclei.
Nevertheless, even if small increments in nuclear uptake
were overlooked by us, this would not change the
observation that transgene expression was unaffected by
the presence of a DTS. We conclude that the DTS effect
may occur at the level of nuclear import but is obscured by
effects on any of the other steps involved (i.e. transcription,
translation). In our study, plasmids in which transcription
was controlled by the strong CMV-promoter were used to
ensure detectable expression levels in poorly transfectable
non-dividing cells. We propose the following hypothesis,
which is schematically presented in Fig. 7. When using a
strong promoter, the bottleneck is at the (post-)transcrip-
tional level, and increments in pre-transcriptional processes,
including nuclear uptake, do not affect overall gene
expression levels. In contrast, when using a weak promoter,
the transcription machinery is not saturated, and
increases in nuclear delivery of plasmids lead to
increased transcription and translation (until translation
is saturated), hence increased transgene expression. In
support of this hypothesis, a threshold for nuclear
delivery of plasmids has been described above which
additional plasmids no longer result in increased
expression (47,60). This means that above this threshold,
processes following nuclear uptake become the limiting
factor, possibly subnuclear disposition or translation (17).
The presented hypothesis also explains discrepancies
between our results and findings by others. For example,
Gonçalves et al. (54) and Breuzard et al. (41) describe the
optimization of an extended NFκB DNA binding site and
show that insertion of these NFκB binding sites into pTal, a
plasmid in which luciferase is driven by a minimal
promoter, increased transgene expression levels 1,600-fold
and an additional 8-fold after stimulation with TNF-α as
compared to the control plasmid. Expression levels
obtained with the modified plasmid reached similar levels
as an unrelated plasmid in which luciferase was under
control of the strong CMV-promoter. When looking at
nuclear delivery, the NFκB-modified plasmid was reported
to deliver 6-fold more copies than the control vector, and 4-
fold more than the CMV-luc plasmid (5 h after transfection
of TNF-α stimulated HeLa cells). No constructs in which
NFκB binding sites were combined with the CMV-
promoter were tested. Nevertheless, the observation that
much less CMV-luc is delivered into nuclei than the NFκB-
modified plasmid, although expression levels are similar,
supports our findings/hypothesis.
Similarly, Mesika et al. (42) showed a 12-fold increase in
transfection efficiency after insertion of repetitive NFκB
binding sites into a construct in which expression is under
the control of the SV40 promoter, which is considerably
weaker than the CMV promoter (62).
In the case of Thanaketpaisarn et al. (63), increased
expression is in fact observed upon insertion of NFκB binding
sites into a CMV-driven plasmid. Possibly, this is due to the
position of the NFκB-sites within the plasmid. DTSs can elicit
two effects: one is promoting nuclear uptake and is thought to
be position-independent, whereas the other one is transcrip-
tional enhancement which is position-dependent (41). Tha-
naketpaisarn et al. have cloned the NFκB-sites directly
Cellular uptake Intracellular transport Nuclear uptake Transcription
Strong promoter
Weak promoter
Translation Fig. 7 Schematic presentation of
hypothesized bottlenecks (black
arrows) for transgene expression
of plasmid driven by a strong
or weak promoter.
DNA Nuclear Targeting Sequences 1719upstream the CMV-promoter, and they may therefore be
involved in direct enhancement of CMV-driven transcription,
whereas in our constructs the DTSs were cloned downstream
of the coding sequence. Indeed, the authors mention in their
discussion that no significant difference in amount of plasmid
in the nuclear fraction was found.
CONCLUSION AND PROSPECTS
Although DNA nuclear Targeting Sequences can increase
nuclear delivery of plasmids, no significant benefits for
overall transgene expression are obtained if combined with
strong promoters. The added value of DTS may lie in
compensating for weak promoters. Weak promoters can be
a useful alternative to the strong CMV promoter to
minimize immunological responses and promoter shutdown
in vivo and for transcriptional targeting.
Besidestheirrelevanceforimprovingefficiencyofnon-viral
gene delivery, DTSs are of value from a mechanistic point of
view to gain insight into cytonucleoplasmic transport of
macromolecules. In this respect, focusing on well-defined
homogeneous DTS is preferred over heterogeneous DTS
such as the SV40 enhancer region. Using such homogeneous
DTS, research should be directed at studying the nature and
kinetics of protein-DNA interaction. First, it would be
valuable to identify which proteins interact with a DTS and
which of these proteins are able to fulfill a role in facilitating
nuclear import of the DTS-containing plasmid. Not all
proteins that contain a DNA binding domain and an NLS
can act to shuttle DNA into the nucleus, and it is thought that
the overall organization and structure of the DNA-TF
complex might be important (for example, spacing between
theDNAbindingdomain andtheNLS).Subsequently,efforts
to optimize interaction between the protein and DNA could
bemade.StudiesperformedbyGonçalveset al. (54)s h o wt h a t
optimization of the DTS sequence is important and that
spacing between repetitive binding sites has a strong effect on
transfection efficiency.
Second, it would be interesting to study if and how this
interaction takes place with plasmid DNA while complexed
with its carrier inside the cell cytosol. Gonçalves et al. (54)
performed a cross-linked immunoprecipitation assay with
antibodies directed against NFκB and found that plasmid
DNA was present in the immunocomplexes, indicating
cytoplasmic interaction of plasmid with NFkB. However, it
remains elusive whether this interaction occurred in the
presence of carrier, as the carrier is likely to dissociate during
the cell work-up which includes triton and SDS treatments.
In our hands, treatment with these detergents disassembled
plasmid/pEI complexes (not shown). Future studies regard-
ing the kinetics of vector disassembly, the kinetics of
transcription factor activation (under normal conditions, in
diseased tissues and in response to drugs) and binding of
those transcription factors to DTS within the plasmid ‘to be
delivered’ will help to understand and exploit processes by
which plasmid DNA can gain access to the cell nucleus.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License
which permits any noncommercial use, distribution, and
reproduction in any medium, provided the original author(s)
and source are credited.
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